FDA Inspection 1285718 — Rebecca A. Kazin, MD
The FDA completed an inspection of Rebecca A. Kazin, MD on September 25, 2025 in North Bethesda, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 25, 2025
- Fiscal Year
- 2025
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- North Bethesda, MD (United States)
Additional Details
Clinical Investigator (CI)